Deanna W.

Deanna W. is an experienced professional in biomarker operations and strategy, currently serving as the Director of Biomarker Operations and Strategy at Inhibrx, Inc. since August 2022. Prior to this role, Deanna held various positions at Genentech from April 2004 to August 2022, culminating in the role of Sr. Clinical Biomarker Operations Manager. Responsibilities included collaboration with Biomarker Leads and Clinical Operations to develop biomarker strategies for clinical trials, overseeing sample collection and vendor management, and facilitating cross-functional teams to improve workflows. Deanna's career also includes positions at Exelixis Pharmaceuticals, the University of Oregon, the University of Arizona, and the University of California at Davis, with research focused on drug validation and genetic studies. Deanna holds a Master of Science in Molecular and Cellular Biology from the University of Arizona and a Bachelor of Science in Biochemistry from the University of California, Davis.